CD11c- and CD123-positive dendritic cells in development of antitumour immunity in non-small cell lung cancer patients.

In conclusion results suggest that CD11c- and CD123-positive DCs play an important role in antitumour immunity and can be predictive factor for tumour development in patients with NSCLC. PMID: 31556561 [PubMed - in process]
Source: Polish Journal of Pathology - Category: Pathology Tags: Pol J Pathol Source Type: research